For more than a thousand years, systems of power have policed pleasure — what people feel, what they consume, and how they connect. Cannabis never existed in isolation. It was grouped with sexual liberation, psychedelics, and music movements, then controlled under...
The race to the highest THC percentage is losing steam. Educated buyers now ask what a product does, not just how strong it is, and that shift is rewriting cannabis market trends across cultivation, retail, and manufacturing. Minor cannabinoids sit at the center of...
How a cannabinoid enters the body shapes everything that follows. Route of administration drives onset time, bioavailability, dose consistency, and ultimately whether patients stick with a product. An oral edible may take an hour to work and lose much of its potency...
Mental health treatment is shifting fast, and two once-taboo categories now sit at the center of it. Cannabis and psychedelics are moving from the margins toward clinical legitimacy, with mounting evidence supporting their use for anxiety, depression, PTSD, and...
Insurance remains one of the hardest walls between cannabis and the patients who need it. Despite expanding medical programs, most plans still refuse to cover cannabis products, leaving patients to pay out of pocket and pushing many toward the illicit market. For...
